PRDM1 Antikörper (AA 501-600)

Produktnummer ABIN1387860

Produktdetails anti-PRDM1 Antikörper

Target: PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))

Bindungsspezifität: AA 501-600

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRDM1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (Cultured Cells) (IF (cc))

Kreuzreaktivität: Maus

Homologie: Human,Rat,Cow,Pig,Horse,Chicken,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human PRDM1/Blimp1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu PRDM1

Target: PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))

Andere Bezeichnung: PRDM1 (PRDM1 Produkte)

Synonyme: GB11750 antikoerper, CG5249 antikoerper, Dmel\\CG5249 antikoerper, blimp-1 antikoerper, dBlimp-1 antikoerper, dBlimp1 antikoerper, Blimp-1 antikoerper, Blimp1 antikoerper, nrd antikoerper, prdm1 antikoerper, ubo antikoerper, wu:fb99c12 antikoerper, zgc:91885 antikoerper, MGC52536 antikoerper, PRDM1 antikoerper, blimp1 antikoerper, xblimp1 antikoerper, prdi-bf1 antikoerper, BLIMP1 antikoerper, PRDI-BF1 antikoerper, ZNFPR1A1 antikoerper, PR/SET domain 1 antikoerper, probable serine/threonine-protein kinase DDB_G0282963 antikoerper, CG5249 gene product from transcript CG5249-RF antikoerper, blimp-1 antikoerper, PR domain containing 1a, with ZNF domain antikoerper, PR domain 1 S homeolog antikoerper, B lymphocyte induced maturation protein 1 antikoerper, PR domain 1 antikoerper, PR domain containing 1, with ZNF domain antikoerper, PRDM1 antikoerper, LOC408295 antikoerper, Blimp-1 antikoerper, CpipJ_CPIJ007425 antikoerper, prdm1a antikoerper, prdm1.S antikoerper, prdm1 antikoerper, Prdm1 antikoerper

Hintergrund:

Synonyms: Blimp 1, Blimp-1, B Lymphocyte Induced Maturation Protein 1, Beta interferon gene positive regulatory domain I binding factor, Beta-interferon gene positive regulatory domain I-binding factor, BLIMP-1, BLIMP1, Positive Regulatory Domain I Binding Factor 1, Positive regulatory domain I-binding factor 1, PR Domain Containing 1, PR domain containing 1 with ZNF domain, PR domain containing 1 with ZNF domain isoform 2, PR domain containing protein 1, PR domain zinc finger protein 1, PR domain-containing protein 1, PRDI BF1, PRDI binding factor 1, PRDI-BF1, PRDI-binding factor 1, PRDM 1, Prdm1, PRDM1_HUMAN.

Background: The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.

Gen-ID: 144423

Pathways: Regulation of Muscle Cell Differentiation